Skip to main content

Advertisement

SpringerLink
Log in

Diagnosis and treatment of benign inflammatory esophageal diseases

  • Original Article
  • Published:
European Surgery Aims and scope Submit manuscript

Summary

Background

Nowadays, benign inflammatory esophageal diseases represent a rising socioeconomic burden. Recently, novel therapeutic approaches have been introduced to enrich personalized surgical options.

Methods

A PubMed research was conducted and merged with institutional guidelines and data.

Results

Magnetic sphincter augmentation strengthens the lower esophageal sphincter and therefore recreates the natural reflux barrier. Electrical sphincter stimulation offers the possibility to personalize minimal invasive treatment and considers even changing lifestyles. Endoscopic antireflux procedures try to mimic the outcome of laparoscopic fundoplication and aim to improve the angle of His. However, laparoscopic fundoplication remains the surgical treatment of choice in advanced reflux disease.

Reflux can also cause eosinophilic infiltration and therefore hinders diagnosis of eosinophilic esophagitis. Once diagnosis is established, dietary modifications and topical steroids offer relevant relief. Reflux produces Barrett’s esophagus, a neoplastic progression, which is commonly treated with radiofrequency ablation.

Conclusion

Novel therapeutic options are facing the rising incidence of benign inflammatory diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014;63(6):871–80.

    PubMed Central  PubMed  Google Scholar 

  2. Edelstein ZR, Farrow DC, Bronner MP, Rosen SN, Vaughan TL. Central adiposity and risk of Barrett’s esophagus. Gastroenterology. 2007;133(2):403–11.

    PubMed  Google Scholar 

  3. Spechler SJ, Souza RF. Barrett’s esophagus. N Engl J Med. 2014;371(9):836–45.

    CAS  PubMed  Google Scholar 

  4. van Soest EM, Dieleman JP, Siersema PD, Sturkenboom MC, Kuipers EJ. Increasing incidence of Barrett’s oesophagus in the general population. Gut. 2005;54(8):1062–6.

    PubMed Central  PubMed  Google Scholar 

  5. Oezcelik A, Ayazi S, DeMeester SR, et al. Adenocarcinoma of the esophagus in the young. J Gastrointest Surg. 2013;17(6):1032–5.

    PubMed  Google Scholar 

  6. Mulder DJ, Justinich CJ. Understanding eosinophilic esophagitis: the cellular and molecular mechanisms of an emerging disease. Mucosal Immunol. 2011;4(2):139–47.

    CAS  PubMed  Google Scholar 

  7. Ma X, Xu Q, Zheng Y, et al. Prevalence of esophageal eosinophilia and eosinophilic esophagitis in adults: a population-based endoscopic study in Shanghai, China. Dig Dis Sci. 2015;60(6):1716–23.

    PubMed  Google Scholar 

  8. Gonsalves N, Yang GY, Doerfler B, Ritz S, Ditto AM, Hirano I. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology. 2012;142(7):1451–9.

    PubMed  Google Scholar 

  9. Moawad FJ, Veerappan GR, Lake JM, et al. Correlation between eosinophilic oesophagitis and aeroallergens. Aliment Pharmacol Ther. 2010;31(4):509–15.

    CAS  PubMed  Google Scholar 

  10. Winter HS, Madara JL, Stafford RJ, Grand RJ, Quinlan JE, Goldman H. Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis. Gastroenterology. 1982;83(4):818–23.

    CAS  PubMed  Google Scholar 

  11. Dellon ES, Liacouras CA. Advances in clinical management of eosinophilic esophagitis. Gastroenterology. 2014;147(6):1238–54.

    PubMed  Google Scholar 

  12. Attwood SE, Smyrk TC, Demeester TR, Jones JB. Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci. 1993;38(1):109–16.

    CAS  PubMed  Google Scholar 

  13. Philpott H, Nandurkar S, Thien F, Gibson PR, Royce SG. Eosinophilic esophagitis: a clinicopathological review. Pharmacol Ther. 2015;146:12–22.

    CAS  PubMed  Google Scholar 

  14. Klauser AG, Schindlbeck NE, Muller-Lissner SA. Symptoms in gastro-oesophageal reflux disease. Lancet. 1990;335(8683):205–8.

    CAS  PubMed  Google Scholar 

  15. Badillo R, Francis D. Diagnosis and treatment of gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther. 2014;5(3):105–12.

    PubMed Central  PubMed  Google Scholar 

  16. Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108(3):308–28.

    PubMed  Google Scholar 

  17. Sifrim D, Castell D, Dent J, Kahrilas PJ. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut. 2004;53(7):1024–31.

    CAS  PubMed Central  PubMed  Google Scholar 

  18. Kwiatek MA, Pandolfino JE, Hirano I, Kahrilas PJ. Esophagogastric junction distensibility assessed with an endoscopic functional luminal imaging probe (EndoFLIP). Gastrointest Endosc. 2010;72(2):272–8.

    PubMed Central  PubMed  Google Scholar 

  19. Angelchik JP, Cohen R. A new surgical procedure for the treatment of gastroesophageal reflux and hiatal hernia. Surg Gynecol Obstet. 1979;148(2):246–8.

    CAS  PubMed  Google Scholar 

  20. Samelson SL, Weiser HF, Bombeck CT, et al. A new concept in the surgical treatment of gastroesophageal reflux. Ann Surg. 1983;197(3):254–9.

    CAS  PubMed Central  PubMed  Google Scholar 

  21. Kauten JR, Mansour KA. Complications of the Angelchik prosthesis in the management of gastroesophageal reflux. Am Surg. 1986;52(4):208–13.

    CAS  PubMed  Google Scholar 

  22. Bonavina L, Saino G, Lipham JC, Demeester TR. LINX(®) reflux management system in chronic gastroesophageal reflux: a novel effective technology for restoring the natural barrier to reflux. Therap Adv Gastroenterol. 2013;6(4):261–8.

    PubMed Central  PubMed  Google Scholar 

  23. Ganz RA, Gostout CJ, Grudem J, Swanson W, Berg T, DeMeester TR. Use of a magnetic sphincter for the treatment of GERD: a feasibility study. Gastrointest Endosc. 2008;67(2):287–94.

    PubMed  Google Scholar 

  24. Bonavina L, Saino GI, Bona D, et al. Magnetic augmentation of the lower esophageal sphincter: results of a feasibility clinical trial. J Gastrointest Surg. 2008;12(12):2133–40.

    PubMed  Google Scholar 

  25. Bonavina L, DeMeester T, Fockens P, et al. Laparoscopic sphincter augmentation device eliminates reflux symptoms and normalizes esophageal acid exposure: one- and 2-year results of a feasibility trial. Ann Surg. 2010;252(5):857–62.

    PubMed  Google Scholar 

  26. Lipham JC, DeMeester TR, Ganz RA, et al. The LINX(R) reflux management system: confirmed safety and efficacy now at 4 years. Surg Endosc. 2012;26(10):2944–9.

    PubMed  Google Scholar 

  27. Ganz RA, Peters JH, Horgan S, et al. Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med. 2013;368(8):719–27.

    CAS  PubMed  Google Scholar 

  28. Miholic J, Sporn E. Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med. 2013;368(21):2038–9.

    CAS  PubMed  Google Scholar 

  29. Riegler M, Schoppman SF, Bonavina L, Ashton D, Horbach T, Kemen M. Magnetic sphincter augmentation and fundoplication for GERD in clinical practice: one-year results of a multicenter, prospective observational study. Surg Endosc. 2014;29(5):1123–9.

    PubMed  Google Scholar 

  30. Bonavina L, Saino G, Bona D, Sironi A, Lazzari V. One hundred consecutive patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease: 6 years of clinical experience from a single center. J Am Coll Surg. 2013;217(4):577–85.

    PubMed  Google Scholar 

  31. Schwameis K, Schwameis M, Zorner B, et al. Modern GERD treatment: feasibility of minimally invasive esophageal sphincter augmentation. Anticancer Res. 2014;34(5):2341–8.

    PubMed  Google Scholar 

  32. Lipham JC, Taiganides PA, Louie BE, Ganz RA, Demeester TR. Safety analysis of first 1000 patients treated with magnetic sphincter augmentation for gastroesophageal reflux disease. Dis Esophagus. 2014;28(4):305–11.

    PubMed  Google Scholar 

  33. Ellis F, Berne TV, Settevig K. The prevention of experimentally induced reflux by electrical stimulation of the distal esophagus. Am J Surg. 1968;115(4):482–7.

    CAS  PubMed  Google Scholar 

  34. Clarke JO, Jagannath SB, Kalloo AN, Long VR, Beitler DM, Kantsevoy SV. An endoscopically implantable device stimulates the lower esophageal sphincter on demand by remote control: a study using a canine model. Endoscopy. 2007;39(1):72–6.

    CAS  PubMed  Google Scholar 

  35. Sanmiguel CP, Hagiike M, Mintchev MP, et al. Effect of electrical stimulation of the LES on LES pressure in a canine model. Am J Physiol Gastrointest Liver Physiol. 2008;295(2):G389–94.

    CAS  PubMed  Google Scholar 

  36. Rodriguez L, Rodriguez P, Neto MG, et al. Short-term electrical stimulation of the lower esophageal sphincter increases sphincter pressure in patients with gastroesophageal reflux disease. Neurogastroenterol Motil. 2012;24(5):446–50, e213.

    CAS  PubMed  Google Scholar 

  37. Eypasch E. Electrical stimulation of the lower esophageal sphincter: an emerging therapy for treatment of GORD. Eur Surg. 2014;46(2):57–64.

    Google Scholar 

  38. Banerjee R, Pratap N, Kalpala R, Reddy DN. Effect of electrical stimulation of the lower esophageal sphincter using endoscopically implanted temporary stimulation leads in patients with reflux disease. Surg Endosc. 2014;28(3):1003–9.

    PubMed  Google Scholar 

  39. Rodriguez L, Rodriguez P, Gomez B, et al. Long-term results of electrical stimulation of the lower esophageal sphincter for the treatment of gastroesophageal reflux disease. Endoscopy. 2013;45(8):595–604.

    CAS  PubMed  Google Scholar 

  40. Siersema P, Smout A, Conchillo J, Booth M, Ruurda J, Wu J. Electric stimulation therapy (EST) of the lower esophageal sphincter (LES): an effective therapy for refractory GERD—interim results of an International multicenter trial. Am J Gastroenterol. 2013;108:S28.

    Google Scholar 

  41. Shaheen NJ. The rise and fall (and rise?) of endoscopic anti-reflux procedures. Gastroenterology. 2006;131(3):952–4.

    PubMed  Google Scholar 

  42. Arts J, Bisschops R, Blondeau K, et al. A double-blind sham-controlled study of the effect of radiofrequency energy on symptoms and distensibility of the gastro-esophageal junction in GERD. Am J Gastroenterol. 2012;107(2):222–30.

    CAS  PubMed  Google Scholar 

  43. Schiefke I, Zabel-Langhennig A, Neumann S, Feisthammel J, Moessner J, Caca K. Long term failure of endoscopic gastroplication (EndoCinch). Gut. 2005;54(6):752–8.

    CAS  PubMed Central  PubMed  Google Scholar 

  44. Wong RF, Davis TV, Peterson KA. Complications involving the mediastinum after injection of Enteryx for GERD. Gastrointest Endosc. 2005;61(6):753–6.

    PubMed  Google Scholar 

  45. Bell RC, Cadiere GB. Transoral rotational esophagogastric fundoplication: technical, anatomical, and safety considerations. Surg Endosc. 2011;25(7):2387–99.

    PubMed Central  PubMed  Google Scholar 

  46. Jobe BA, O’Rourke RW, McMahon BP, et al. Transoral endoscopic fundoplication in the treatment of gastroesophageal reflux disease: the anatomic and physiologic basis for reconstruction of the esophagogastric junction using a novel device. Ann Surg. 2008;248(1):69–76.

    PubMed  Google Scholar 

  47. Cadiere GB, Rajan A, Germay O, Himpens J. Endoluminal fundoplication by a transoral device for the treatment of GERD: a feasibility study. Surg Endosc. 2008;22(2):333–42.

    CAS  PubMed  Google Scholar 

  48. Witteman BP, Strijkers R, de Vries E, et al. Transoral incisionless fundoplication for treatment of gastroesophageal reflux disease in clinical practice. Surg Endosc. 2012;26(11):3307–15.

    PubMed Central  PubMed  Google Scholar 

  49. Testoni PA, Testoni S, Mazzoleni G, Vailati C, Passaretti S. Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study. Surg Endosc. 2014. Epub ahead of print.

  50. Hunter JG, Kahrilas PJ, Bell RC, et al. Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial. Gastroenterology. 2015;148(2):324–33, e325.

    CAS  PubMed  Google Scholar 

  51. Trad KS, Barnes WE, Simoni G, et al. Transoral incisionless fundoplication effective in eliminating GERD symptoms in partial responders to proton pump inhibitor therapy at 6 months: the TEMPO randomized clinical trial. Surg Innov. 2015;22(1):26–40.

    PubMed Central  PubMed  Google Scholar 

  52. Zacherl J, Roy-Shapira A, Bonavina L, et al. Endoscopic anterior fundoplication with the medigus ultrasonic surgical endostapler (MUSE) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial. Surg Endosc. 2015;29(1):220–9.

    PubMed Central  PubMed  Google Scholar 

  53. Dallemagne B, Weerts J, Markiewicz S, et al. Clinical results of laparoscopic fundoplication at 10 years after surgery. Surg Endosc. 2006;20(1):159–65.

    CAS  PubMed  Google Scholar 

  54. Vakil N, Shaw M, Kirby R. Clinical effectiveness of laparoscopic fundoplication in a U.S. community. Am J Med. 2003;114(1):1–5.

    PubMed  Google Scholar 

  55. Humphries LA, Hernandez JM, Clark W, Luberice K, Ross SB, Rosemurgy AS. Causes of dissatisfaction after laparoscopic fundoplication: the impact of new symptoms, recurrent symptoms, and the patient experience. Surg Endosc. 2013;27(5):1537–45.

    PubMed  Google Scholar 

  56. Dominitz JA, Dire CA, Billingsley KG, Todd-Stenberg JA. Complications and antireflux medication use after antireflux surgery. Clin Gastroenterol Hepatol. 2006;4(3):299–305.

    PubMed  Google Scholar 

  57. Spechler SJ, Lee E, Ahnen D, et al. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA. 2001;285(18):2331–8.

    CAS  PubMed  Google Scholar 

  58. Galmiche JP, Hatlebakk J, Attwood S, et al. Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA. 2011;305(19):1969–77.

    CAS  PubMed  Google Scholar 

  59. Wileman SM, McCann S, Grant AM, Krukowski ZH, Bruce J. Medical versus surgical management for gastro-oesophageal reflux disease (GORD) in adults. Cochrane Database Syst Rev. 2010;17(3):CD003243.

    Google Scholar 

  60. Rickenbacher N, Kotter T, Kochen MM, Scherer M, Blozik E. Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis. Surg Endosc. 2014;28(1):143–55.

    PubMed  Google Scholar 

  61. Hayeck TJ, Kong CY, Spechler SJ, Gazelle GS, Hur C. The prevalence of Barrett’s esophagus in the US: estimates from a simulation model confirmed by SEER data. Dis Esophagus. 2010;23(6):451–7.

    CAS  PubMed Central  PubMed  Google Scholar 

  62. Hvid-Jensen F, Pedersen L, Drewes AM, Sorensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett’s esophagus. N Engl J Med. 2011;365(15):1375–83.

    CAS  PubMed  Google Scholar 

  63. Bonavina L. Selected commentary to review on novel concepts of columnar lined esophagus. Eur Surg. 2014;46:96–7.

    Google Scholar 

  64. Sharma P, Morales TG, Sampliner RE. Short segment Barrett’s esophagus—the need for standardization of the definition and of endoscopic criteria. Am J Gastroenterol. 1998;93(7):1033–6.

    CAS  PubMed  Google Scholar 

  65. Sharma P, Dent J, Armstrong D, et al. The development and validation of an endoscopic grading system for Barrett’s esophagus: the Prague C and M criteria. Gastroenterology. 2006;131(5):1392–9.

    PubMed  Google Scholar 

  66. Levine DS, Blount PL, Rudolph RE, Reid BJ. Safety of a systematic endoscopic biopsy protocol in patients with Barrett’s esophagus. Am J Gastroenterol. 2000;95(5):1152–7.

    CAS  PubMed  Google Scholar 

  67. American Gastroenterological Association, Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ. American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology. 2011;140(3):1084–91.

    PubMed  Google Scholar 

  68. Iezzi R, Pompili M, La Torre MF, et al. Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma. Dig Liver Dis. 2015;47(3):242–8.

    PubMed  Google Scholar 

  69. Chang X, Liu T, Zhang F, et al. Radiofrequency ablation versus partial nephrectomy for clinical T renal-cell carcinoma: long-term clinical and oncologic outcomes based on a propensity score analysis. J Endourol. 2015;29(5):518–25.

    PubMed  Google Scholar 

  70. Rombouts SJ, Vogel JA, van Santvoort HC, et al. Systematic review of innovative ablative therapies for the treatment of locally advanced pancreatic cancer. Br J Surg. 2015;102(3):182–93.

    CAS  PubMed  Google Scholar 

  71. Kristo I, Asari R, Rieder E, Riegler M, Schoppmann SF. Treatment of Barrett’s esophagus: update on new endoscopic surgical modalities. Minerva Chir. 2015;70(2):107–18.

    CAS  PubMed  Google Scholar 

  72. Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med. 2009;360(22):2277–88.

    CAS  PubMed  Google Scholar 

  73. Shaheen NJ, Overholt BF, Sampliner RE, et al. Durability of radiofrequency ablation in Barrett’s esophagus with dysplasia. Gastroenterology. 2011;141(2):460–8.

    PubMed Central  PubMed  Google Scholar 

  74. Phoa KN, Pouw RE, van Vilsteren FG, et al. Remission of Barrett’s esophagus with early neoplasia 5 years after radiofrequency ablation with endoscopic resection: a Netherlands cohort study. Gastroenterology. 2013;145(1):96–104.

    PubMed  Google Scholar 

  75. Dunbar KB, Spechler SJ. The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett’s esophagus: a systematic review. Am J Gastroenterol. 2012;107(6):850–62;.

    PubMed Central  PubMed  Google Scholar 

  76. Heitmiller RF. Prophylactic esophagectomy in Barrett esophagus with high-grade dysplasia. Langenbecks Arch Surg. 2003;388(2):83–7.

    PubMed  Google Scholar 

  77. Phoa KN, van Vilsteren FG, Weusten BL, et al. Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. JAMA. 2014;311(12):1209–17.

    CAS  PubMed  Google Scholar 

  78. Riegler FM, Schoppmann SF. Selected commentary to “Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grad dysplasia. A randomized clinical trial”. Eur Surg. 2014;46:133–6.

    Google Scholar 

  79. Hur C, Choi SE, Rubenstein JH, et al. The cost effectiveness of radiofrequency ablation for Barrett’s esophagus. Gastroenterology. 2012;143(3):567–75.

    PubMed Central  PubMed  Google Scholar 

  80. Committee ASoP, Evans JA, Early DS, Fukami N, et al. Standards of Practice Committee of the American Society for Gastrointestinal Endoscopy. The role of endoscopy in Barrett’s esophagus and other premalignant conditions of the esophagus. Gastrointest Endosc. 2012;76(6):1087–94.

  81. Fitzgerald RC, di Pietro M, Ragunath K. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63(1):7–42.

    PubMed  Google Scholar 

  82. Liacouras CA, Spergel JM, Ruchelli E, et al. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol. 2005;3(12):1198–206.

    PubMed  Google Scholar 

  83. Sgouros SN, Bergele C, Mantides A. Eosinophilic esophagitis in adults: a systematic review. Eur J Gastroenterol Hepatol. 2006;18(2):211–7.

    PubMed  Google Scholar 

  84. Desai TK, Stecevic V, Chang CH, Goldstein NS, Badizadegan K, Furuta GT. Association of eosinophilic inflammation with esophageal food impaction in adults. Gastrointest Endosc. 2005;61(7):795–801.

    PubMed  Google Scholar 

  85. Leslie C, Mews C, Charles A, Ravikumara M. Celiac disease and eosinophilic esophagitis: a true association. J Pediatr Gastroenterol Nutr. 2010;50(4):397–9.

    PubMed  Google Scholar 

  86. Dellon ES, Gonsalves N, Hirano I, Furuta GT, Liacouras CA, Katzka DA, American College of Gastroenterolgy. ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013;108(5):679–92.

    PubMed  Google Scholar 

  87. Hirano I. Eosinophilic esophagitis and gastroesophageal reflux disease: there and back again. Clin Gastroenterol Hepatol. 2011;9(2):99–101.

    PubMed  Google Scholar 

  88. Ngo P, Furuta GT, Antonioli DA, Fox VL. Eosinophils in the esophagus—peptic or allergic eosinophilic esophagitis? Case series of three patients with esophageal eosinophilia. Am J Gastroenterol. 2006;101(7):1666–70.

    PubMed  Google Scholar 

  89. Dellon ES, Speck O, Woodward K, et al. Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study. Am J Gastroenterol. 2013;108(12):1854–60.

    CAS  PubMed  Google Scholar 

  90. Saffari H, Peterson KA, Fang JC, Teman C, Gleich GJ, Pease LF 3rd. Patchy eosinophil distributions in an esophagectomy specimen from a patient with eosinophilic esophagitis: implications for endoscopic biopsy. J Allergy Clin Immunol. 2012;130(3):798–800.

    PubMed Central  PubMed  Google Scholar 

  91. Dellon ES. Do you see what I see? Towards standardized reporting of endoscopic findings in eosinophilic esophagitis. Endoscopy. 2014;46(12):1043–5.

    PubMed  Google Scholar 

  92. Schoepfer AM, Safroneeva E, Bussmann C, et al. Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. Gastroenterology. 2013;145(6):1230–6.

    PubMed  Google Scholar 

  93. Kim HP, Vance RB, Shaheen NJ, Dellon ES. The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(9):988–96.

    PubMed Central  PubMed  Google Scholar 

  94. Yazaki E, Woodland P, Sifrim D. Uses of esophageal function testing: dysphagia. Gastrointest Endosc Clin N Am. 2014;24(4):643–54.

    PubMed  Google Scholar 

  95. Hirano I. Role of advanced diagnostics for eosinophilic esophagitis. Dig Dis. 2014;32(1–2):78–83.

    PubMed  Google Scholar 

  96. Kwiatek MA, Hirano I, Kahrilas PJ, Rothe J, Luger D, Pandolfino JE. Mechanical properties of the esophagus in eosinophilic esophagitis. Gastroenterology. 2011;140(1):82–90.

    PubMed Central  PubMed  Google Scholar 

  97. Markowitz JE, Spergel JM, Ruchelli E, Liacouras CA. Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol. 2003;98(4):777–82.

    CAS  PubMed  Google Scholar 

  98. Kagalwalla AF, Sentongo TA, Ritz S, et al. Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2006;4(9):1097–102.

    PubMed  Google Scholar 

  99. Molina-Infante J, Martin-Noguerol E, Alvarado-Arenas M, Porcel-Carreno SL, Jimenez-Timon S, Hernandez-Arbeiza FJ. Selective elimination diet based on skin testing has suboptimal efficacy for adult eosinophilic esophagitis. J Allergy Clin Immunol. 2012;130(5):1200–2.

    PubMed  Google Scholar 

  100. Lucendo AJ, Arias A. Treatment of adult eosinophilic esophagitis with diet. Dig Dis. 2014;32(1–2):120–5.

    PubMed  Google Scholar 

  101. Alexander JA, Jung KW, Arora AS, et al. Swallowed fluticasone improves histologic but not symptomatic response of adults with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2012;10(7):742–9.

    CAS  PubMed  Google Scholar 

  102. Straumann A, Conus S, Degen L, et al. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology. 2010;139(5):1526–37.

    CAS  PubMed  Google Scholar 

  103. von Arnim U, Malfertheiner P. Eosinophilic esophagitis—treatment of eosinophilic esophagitis with drugs: corticosteroids. Dig Dis. 2014;32(1–2):126–9.

    Google Scholar 

  104. Dellon ES, Kim HP, Sperry SL, Rybnicek DA, Woosley JT, Shaheen NJ. A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease. Gastrointest Endosc. 2014;79(4):577–85.

    PubMed  Google Scholar 

  105. Jacobs JW Jr., Spechler SJ. A systematic review of the risk of perforation during esophageal dilation for patients with eosinophilic esophagitis. Dig Dis Sci. 2010;55(6):1512–5.

    CAS  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Upper-GI service, Comprehensive Cancer Center, Gastroesophageal Tumor Unit, Medical University of Vienna, Währinger Gürtel 18–20, 1090, Vienna, Austria

    I. Kristo MD & S.F. Schoppmann MD

Authors
  1. I. Kristo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S.F. Schoppmann MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S.F. Schoppmann MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kristo, I., Schoppmann, S. Diagnosis and treatment of benign inflammatory esophageal diseases. Eur Surg 47, 188–198 (2015). https://doi.org/10.1007/s10353-015-0329-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10353-015-0329-5

Keywords

Search

Navigation